135 related articles for article (PubMed ID: 35930717)
1. FDG PET/CT in a Patient With Syphilis Suspected of Having Penile Cancer.
Jakobsen JK; Szumniak J; Stilling C; Fledelius J; Bouchelouche K
Clin Nucl Med; 2022 Sep; 47(9):e621-e623. PubMed ID: 35930717
[TBL] [Abstract][Full Text] [Related]
2. [18F]FDG PET/CT for assessing inguinal lymph nodes in patients with penile cancer - correlation with histopathology after inguinal lymphadenectomy.
Dräger DL; Heuschkel M; Protzel C; Erbersdobler A; Krause BJ; Hakenberg OW; Schwarzenböck SM
Nuklearmedizin; 2018 Feb; 57(1):26-30. PubMed ID: 29536497
[TBL] [Abstract][Full Text] [Related]
3. F-18 Fluorodeoxyglucose Positron Emission Tomography with Computed Tomography Has High Diagnostic Value for Pelvic and Distant Staging in Patients with High-risk Penile Carcinoma.
Ottenhof SR; Djajadiningrat RS; Versleijen MWJ; Donswijk ML; van der Noort V; Brouwer OR; Graafland NM; Vegt E; Horenblas S
Eur Urol Focus; 2022 Jan; 8(1):98-104. PubMed ID: 33685842
[TBL] [Abstract][Full Text] [Related]
4. DaPeCa-3: promising results of sentinel node biopsy combined with (18) F-fluorodeoxyglucose positron emission tomography/computed tomography in clinically lymph node-negative patients with penile cancer - a national study from Denmark.
Jakobsen JK; Alslev L; Ipsen P; Costa JC; Krarup KP; Sommer P; Nerstrøm H; Toft BG; Høyer S; Bouchelouche K; Jensen JB
BJU Int; 2016 Jul; 118(1):102-11. PubMed ID: 26216234
[TBL] [Abstract][Full Text] [Related]
5. Utility of ¹⁸F-FDG PET/CT in identifying penile squamous cell carcinoma metastatic lymph nodes.
Rosevear HM; Williams H; Collins M; Lightfoot AJ; Coleman T; Brown JA
Urol Oncol; 2012 Sep; 30(5):723-6. PubMed ID: 21396850
[TBL] [Abstract][Full Text] [Related]
6. DaPeCa-7: comparative assessment of fluorodeoxyglucose positron emission tomography/computed tomography (CT) and conventional diagnostic CT in diagnosis of lymph node metastases, distant metastases and incidental findings in patients with invasive penile cancer.
Jakobsen JK; Frahm Nielsen T; Ipsen P; Albrecht-Beste E; Cardoso Costa J; Alslev L; Predbjørn Krarup K; Grønkaer Toft B; Høyer S; Bouchelouche K; Bjerggaard Jensen J
BJU Int; 2021 Feb; 127(2):254-262. PubMed ID: 33448605
[TBL] [Abstract][Full Text] [Related]
7. 18F-FDG PET/CT for staging of penile cancer.
Scher B; Seitz M; Reiser M; Hungerhuber E; Hahn K; Tiling R; Herzog P; Reiser M; Schneede P; Dresel S
J Nucl Med; 2005 Sep; 46(9):1460-5. PubMed ID: 16157528
[TBL] [Abstract][Full Text] [Related]
8. Prospective evaluation of hybrid 18F-fluorodeoxyglucose positron emission tomography/computed tomography in staging clinically node-negative patients with penile carcinoma.
Leijte JA; Graafland NM; Valdés Olmos RA; van Boven HH; Hoefnagel CA; Horenblas S
BJU Int; 2009 Sep; 104(5):640-4. PubMed ID: 19281465
[TBL] [Abstract][Full Text] [Related]
9.
Salazar A; Júnior EP; Salles PGO; Silva-Filho R; Reis EA; Mamede M
Eur J Nucl Med Mol Imaging; 2019 Apr; 46(4):855-863. PubMed ID: 30143840
[TBL] [Abstract][Full Text] [Related]
10. PET/CT in breast cancer staging is useful for evaluation of axillary lymph node and distant metastases.
Davidson T; Shehade N; Nissan E; Sklair-Levy M; Ben-Haim S; Barshack I; Zippel D; Halevy A; Chikman B
Surg Oncol; 2021 Sep; 38():101567. PubMed ID: 33866190
[TBL] [Abstract][Full Text] [Related]
11. Primary penile lymphoma: the use of PET-CT for accurate staging and response monitoring.
Karunanithi S; Sharma P; Naswa N; Soundararajan R; Mohapatra T; Malhotra A; Bal C; Kumar R
Diagn Interv Radiol; 2013; 19(2):130-3. PubMed ID: 23448700
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic Performance of 18F-FDG PET/CT for Lymph Node Staging in Penile Cancer.
Lee SW; Kim SJ
Clin Nucl Med; 2022 May; 47(5):402-408. PubMed ID: 35143458
[TBL] [Abstract][Full Text] [Related]
13. Lack of clinical impact of
Liu J; Larcos G; Howle J; Veness M
Australas J Dermatol; 2017 May; 58(2):99-105. PubMed ID: 26459330
[TBL] [Abstract][Full Text] [Related]
14. Detection of inguinal lymph node involvement in penile squamous cell carcinoma by 18F-fluorodeoxyglucose PET/CT: a prospective single-center study.
Schlenker B; Scher B; Tiling R; Siegert S; Hungerhuber E; Gratzke C; Tilki D; Reich O; Schneede P; Bartenstein P; Stief CG; Seitz M
Urol Oncol; 2012; 30(1):55-9. PubMed ID: 20022269
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic Value of
Voskuilen CS; Schweitzer D; Jensen JB; Nielsen AM; Joniau S; Muilwijk T; Necchi A; Azizi M; Spiess PE; Briganti A; Bandini M; Goffin K; Bouchelouche K; van Werkhoven E; Shariat SF; Xylinas E; Azawi NH; Ku JH; Foerster B; van Rhijn BWG; Vegt E; Hendricksen K
Eur Urol Oncol; 2020 Feb; 3(1):73-79. PubMed ID: 31591037
[TBL] [Abstract][Full Text] [Related]
16. Clinical value of fluorine-18 2-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography in penile cancer.
Zhang S; Li W; Liang F
Oncotarget; 2016 Jul; 7(30):48600-48606. PubMed ID: 27203206
[TBL] [Abstract][Full Text] [Related]
17. F-18 fluoro-D-glucose (FDG)-positron emission tomography (PET)/computed tomography (CT) in planning of surgery and sentinel lymph node screening in vulvar cancers.
Dolanbay M; Ozcelik B; Abdulrezzak U; Serin IS; Kutuk MS; Uludag S
Arch Gynecol Obstet; 2016 Jun; 293(6):1319-24. PubMed ID: 26498604
[TBL] [Abstract][Full Text] [Related]
18. Mesenteric Castleman Disease Misdiagnosed as Lymph Node Metastasis of Rectal Cancer on 18 F-FDG PET/CT.
Liu M; Zhou J; Zhu W; Huo L; Cheng W
Clin Nucl Med; 2023 Nov; 48(11):985-986. PubMed ID: 37703486
[TBL] [Abstract][Full Text] [Related]
19. Factors affecting the accuracy of
Kutluturk K; Simsek A; Comak A; Gonultas F; Unal B; Kekilli E
Niger J Clin Pract; 2019 Jan; 22(1):63-68. PubMed ID: 30666022
[TBL] [Abstract][Full Text] [Related]
20. Congenital Penile Rhabdomyosarcoma on FDG PET/CT.
Wu C; Zhuang H
Clin Nucl Med; 2018 Nov; 43(11):852-853. PubMed ID: 30179913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
